Overview

Patients with cancer are at increased risk of infection due to a number of factors related to both their underlying malignancy and the treatment provided, most commonly from the administration of chemotherapeutic drugs. This text, from an international team of experts, reviews the epidemiology, assessment and treatment of febrile neutropenia in a number of clinical settings.

Full Product Details

Author:   Kenneth V I Rolston ,  Edward B Rubenstein
Publisher:   Taylor & Francis Ltd
Imprint:   CRC Press
Dimensions:   Width: 18.90cm , Height: 2.90cm , Length: 24.60cm
Weight:   1.134kg
ISBN:  

9781841840338

ISBN 10:   1841840335
Pages:   256
Publication Date:   17 May 2001
Audience:   College/higher education ,  General/trade ,  Professional and scholarly ,  Tertiary & Higher Education ,  General
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Out of stock  

Table of Contents

1. Historical Perspectives in Febrile Neutropenia 2. Risk Assessment and Initial Clinical Evaluation of the Febrile Neutropenic Cancer Patient 3. Methodology of Clinical Trials 4. Current Epidemiology of Infections in Neutropenic Cancer Patients 5. Infections in Patients with Solid Tumors 6. Infections in Patients with Hematologic Malignancies 7. Special Considerations in the Febrile Neutropenic Child 8. Guidelines for Hospital-Based Therapy 9. Risk Stratified Therapy/Outpatient Management 10. Cytokines and WBC Transfusions 11. Prophylaxis of Infections 12. Evaluation and Management of Fever in the Neutropenic Transplant Patient 13. Economic Issues 14. Pharmacokinetics/Pharmacodynamics of Antimicrobial Agents 15. Evaluation and Management of Vascular Access Device (VAD) Infections in Febrile Neutropenic Cancer Patients 16. Summary/Future Horizons

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions